Do you need any of these vaginal therapies?

March 26, 2018

 

Sorting out which vaginal therapy to use is complicated, and of course should be done with your personal gyno.

 

Vaginal health for the average woman means: not getting infections, having comfortable  intercourse, being able to be aroused and have an orgasm; vaginal health is also, to most women, about not having bladder symptoms, not having unusual discharge, and not having unusual odor. It can be more complex than those features: vaginal health also means maintaining the pelvic floor, maintaining skin health, and maintaining a youthful look and function to the tissue. Having regular sex, eating and sleeping well, getting vaginal therapies, and proper treatments can do all of those things for best vaginal health!

 

For the FDA, and many physicians, vaginal health is treating sexual pain and vaginal atrophy. While it is true that virtually 100% of women will experience vaginal atrophy and require therapy as they age, it is also true that 100% of women have concerns many years before they are atrophic and to them vaginal health needs to be approached from the wellness aspect we approach cardiovascular health, the way we approach fitness and nutrition: preventative health.

 

While therapies  approved by the US Food and Drug Administration (FDA) abound in treatment of vaginal pain, atrophy and sexual pain due to atrophy, this approach has not begun to address what women are interested in which is staying healthy in the vaginal tissues.

 

There is important good news for those who want to treat vaginal pain as there is a newly approved therapy that joins various estrogens and Osphena as a therapy for dysparunia. The FDA has approved prasterone (Intrarosa, Endoceutics Inc) to treat women with moderate to severe pain during sexual intercourse (dyspareunia) associated with menopause. Prasterone, a once-daily vaginal insert, is the first FDA-approved product containing the active ingredient prasterone, also known as dehydroepiandrosterone (DHEA), which is essentially a prodrug. It is thought to work by being converted to estrogen in the tissues. This step of conversion may be a better alternative or potentially an alternative to combine with other vaginal pain therapies.

 

In reality there are even other therapies that can be used, some women for instance would be treated by compounded testosterone creams, or medications to help improve nerve conductivity through the area.

 

The wrong spermacide, shaving creams and the wrong soaps can be offensive and simple fixes. Many women will say that laser hair reduction helped them avoid the complications and irritations they were experiencing from shaving that made sex less appealing.

 

Estrogen levels decline in vaginal tissues prior to the time of menopause, and then further as you get farther into menopause which may lead to both vulvar and vaginal atrophy (VVA) and contribute to pain during sexual intercourse. Women with vaginal pain, especially with hormonal therapies have to continue getting pap smears, as one of the side effects of these hormonal therapies could be newly abnormal discharge or an abnormal pap. For women wanting to treat vaginal health before they get to the stage of needing medication: that begins many years before menopause, and may involve preventative care with therapies such as MonaLisa Touch, ThermiVa or PRP therapy. Come to Discuss options at Women's Health Practice.

Share on Facebook
Share on Twitter
Share on linkedin
Please reload

FOLLOW ME

  • Black Facebook Icon
  • Black Twitter Icon
  • Black Instagram Icon

STAY UPDATED

POPULAR POSTS

January 5, 2019

January 2, 2019

Please reload

TAGS